Amicus Therapeutics :
FOLD
FOLD
Stock Data
$9.48
$0.10 (1.01%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Amicus Therapeutics Inc is a biotechnology firm dedicated to tackling rare diseases. It's known for Galafold, an innovative oral treatment for adults with Fabry disease, a genetic disorder. The company also works on developing therapies for other conditions, including through partnerships like those with the University of Pennsylvania and GlaxoSmithKline. Founded in 2002 and based in Princeton, New Jersey, Amicus Therapeutics strives to bring precision medicine to those facing life-altering diagnoses.
All Amicus Therapeutics Articles
11 Articles